Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
State Street Corp reported a 5.40% stake in Apellis Pharmaceuticals, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp reported a 5.40% stake in Apellis Pharmaceuticals, Inc., 6,845,031 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 6,845,031
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.40% | 6,845,031 |
Source
Related
- Apellis Pharmaceuticals, Inc.
- State Street Corp
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026